Cost-effectiveness of introducing a maternal vaccine or long-acting monoclonal antibody to prevent infant respiratory syncytial virus disease in Nepal
J Glob Health. 2025 Nov 14;15:04292. doi: 10.7189/jogh.15.04292. ABSTRACT BACKGROUND: The World Health Organization recommends two passive immunisation strategies to prevent respiratory syncytial virus (RSV) …